New Treatments & Clinical Trials for Iron Deficiency Anemia

Iron deficiency anemia affects more than a billion people worldwide and is the most common nutritional deficiency. Treatment typically starts with oral iron supplements or dietary changes, but many people can't absorb enough iron this way. Intravenous iron has become more common for people who don't respond to pills or who lose iron faster than supplements can replace it.

What's actually going on in research

Trials are testing newer IV iron formulations that require fewer infusions, oral iron products designed to reduce side effects and improve absorption, and treatments for underlying conditions that cause iron loss or block absorption. Researchers are also studying hepcidin, a hormone that controls how the body uses iron, as a potential treatment target for chronic anemia.

What to know before you search

Eligibility typically depends on hemoglobin and ferritin levels, cause of iron deficiency, response to prior iron supplements, and any underlying conditions affecting iron absorption or loss.

What types of trials are currently open

• IV iron trials — Testing newer intravenous iron products that may work in one or two infusions instead of multiple visits, comparing safety and how quickly they restore iron levels.
• Oral iron trials — Testing new pill or liquid formulations designed to cause fewer digestive side effects while delivering adequate iron.
• Hepcidin trials — Testing drugs that affect how the body regulates iron, particularly for people with chronic kidney disease or inflammatory conditions.
• Anemia of chronic disease trials — Testing treatments for anemia caused by cancer, kidney disease, or inflammatory conditions where the body has iron but can't use it properly.
• Biomarker studies — Following people with anemia to understand which lab tests best predict who will respond to different treatments.